Literature DB >> 35534343

Respiratory complications and sleep disorders in children with chronic kidney disease: A correlation often underestimated.

M Lelii1, L Senatore2, F Paglialonga3, S Consolo4, G Montini5, A Rocchi6, P Marchisio7, M F Patria8.   

Abstract

Chronic Kidney Disease (CKD) is characterized by a progressive and irreversible loss of kidney function which gradually leads to end-stage kidney disease (ESKD). Virtually all the organs are damaged by the toxicity of uremic compounds. The lungs may be affected and the impaired pulmonary function may be the direct result of fluid retention and metabolic, endocrine and cardiovascular alterations, as well as systemic activation of the inflammation. An increased prevalence in sleep disorders (SD) is also reported in patients with CKD, leading to a further negative impact on overall health and quality of life. While these complex relationships are well documented in the adult population, these aspects remain relatively little investigated in children. The aim of this review is to provide a brief overview of the pathophysiology between lung and kidney and to summarize how CKD may affect respiratory function and sleep in children.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Central apnoea; Chronic kidney disease; End-stage renal disease; Hypoventilation; Lung function; Quality of life; Sleep-disordered breathing

Year:  2022        PMID: 35534343     DOI: 10.1016/j.prrv.2021.12.003

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  1 in total

1.  Eplerenone ameliorates lung fibrosis in unilateral ureteral obstruction rats by inhibiting lymphangiogenesis.

Authors:  Ziqian Liu; Cuijuan Zhang; Juan Hao; Gege Chen; Lingjin Liu; Yunzhao Xiong; Yi Chang; Hui Li; Tatsuo Shimosawa; Fan Yang; Qingyou Xu
Journal:  Exp Ther Med       Date:  2022-08-11       Impact factor: 2.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.